Pericardioperitoneal shunt for the treatment of refractory non-malignant pericardial effusion
Sign Up to like & getrecommendations! Published in 2022 at "Interactive Cardiovascular and Thoracic Surgery"
DOI: 10.1093/icvts/ivac215
Abstract: Abstract We report the case of a 74-year-old man treated for refractory non-malignant pericardial effusion using a pericardioperitoneal shunt. After the failure of conventional pericardiocentesis, a pericardioperitoneal shunt using a Denver shunt was inserted to… read more here.
Keywords: pericardial effusion; non malignant; refractory non; shunt ... See more keywords
Percutaneous intramyocardial septal radiofrequency ablation: a novel treatment for drug-refractory non-obstructive hypertrophic cardiomyopathy with severe septal hypertrophy
Sign Up to like & getrecommendations! Published in 2025 at "Heart"
DOI: 10.1136/heartjnl-2024-325334
Abstract: Background Patients with drug-refractory non-obstructive hypertrophic cardiomyopathy (NOHCM) lack effective invasive treatment options. This study aimed to evaluate the safety and effectiveness of percutaneous intramyocardial septal radiofrequency ablation (PIMSRA, Liwen procedure) in patients with NOHCM… read more here.
Keywords: refractory non; drug refractory; drug; cardiomyopathy ... See more keywords
A phase I study of the EZH2 inhibitor TR115 in patients with relapsed/refractory non-Hodgkin's lymphomas and advanced solid tumors.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.7053
Abstract: 7053 Background: EZH2 gain-of-function mutations and overexpression lead to aberrant H3K27me3 levels and result in tumorigenesis and metastasis, including several categories of B cell and T cell lymphoid malignancies, and it is associated with poor… read more here.
Keywords: non hodgkin; refractory non; lymphoma; relapsed refractory ... See more keywords